Furthermore, CAR showed a trend towards significant associations with 8MWT (adjusted R 2 = .226, R 2 change = .174 F = 2.312, P = .109, β = .452, P = .064) and 6MWT (adjusted R 2 = .236, R 2 change = .182 F = 2.387, P = .101, β =−.472, P = .058).
At day 28, the abaloparatide group showed a trend toward greater BV vs vehicle (multiplicity‐adjusted P = .109; Table 2 ).
Evaluation of the entire cohort demonstrated that patients treated with IST > 0 and < 35 days showed a trend to improved overall survival (IST 0 vs. > 35 vs. < 35 was 533: 95%CI 446 - 620 vs. 448: 95%CI 361 - 535 vs. 1169: 95%CI 800 - 1538 days, p=0.109, log-rank test) (See Figure 3 and Table 2 ).
The second t -test between SCS implant date and 6-months post-SCS implant was not statistically significant but showed a trend (p = .109).
EV TF activity showed a trend toward correlating with D-dimer levels ( P = .109).
This increase was statistically significant for non-IRIS controls (p = 0.031), while TB-IRIS patients showed a trend (p = 0.109).
Compared with the ADNI-1-matched cohort, subjects on ALZ-801 showed a trend to decreased atrophy at 52 weeks ( p = 0.109) that became statistically significant at 104 weeks ( p = 0.0014), as shown in Fig. 4 .
In the results of this study, although no statistical differences were shown, workers with single exposure to noise still showed a trend toward an increased risk of developing hypertension (OR, 1.79; 95% CI, 0.88–3.65; P = 0.109) after adjusting for age, sex, and BMI in model 3, which are confounding factors that may affect the results.
Nevertheless, comparison between the preoperative impedance and the one measured after the 3rd stimulation week showed a trend towards increased values for the uncoated group (p = 0.109), while for the coated electrodes almost no difference was found (all p values >0.800).
CCI) back to SHAM levels and showed a trend towards restoration to SHAM levels with Tyr1325 (p = 0.1091; CCI + NYX-2925 vs.
As predicted, lmo2316 was significantly upregulated ( p = 0.0014) and lmo1119 showed a trend toward downregulation during intracellular growth ( p = 0.1091; Figure 5A ).
Results for CHR with improved disease burden showed a trend towards higher rates in the ropeginterferon arm vs control (55.1% vs 37.1%, respectively; RR: 1.49 [95% CI: 0.91 to 2.43], p = 0.1092 in patients < 60 years; 43.5% vs 36.1%; RR: 1.22 [95% CI: 0.70 to 2.11], p = 0.4774 in those ≥60 years; Fig. 1 B i ; Supplementary Digital Content, Table 7).
Additionally, L-Ac-SDKP treatment showed a trend to reduce the mRNA expression of Il6 ( p = 0.1094 vs.
Non-selective NSAIDs showed a trend (HR 0.85, 95% CI 0.69 to 1.04, p=0.1094) without reaching statistical significance, and initiation timing, duration, or dose did not significantly affect PFS in this subgroup.
However, TB co-infected individuals showed a trend toward higher rates of increase in CD4 cells compared to non-TB patients (9.55 cells/mm 3 versus 8.66 cells/mm 3 per month, p = 0.1097).
Complex III (2.5 μM Antimycin A) and pyruvate dehydrogenase‐supported mH 2 O 2 (10 mM pyruvate, 0.5 μM Rotenone to inhibit Complex I) were decreased in the Quad (−53%, P = 0.05) and WG (−60%, P < 0.05), while the diaphragm showed a trend for increased Complex III mH 2 O 2 (+35%, P = 0.11) and no differences in pyruvate dehydrogenase‐supported mH 2 O 2 between D2. mdx and WT (Supporting Information, Figure S4A and S4B ).
The pooled results showed a trend toward a higher risk of neurovascular complications associated with TC-TAVR, without reaching statistical significance (RR, 1.36, 95% CI, 0.94–1.99, p = 0.11), and with no heterogeneity ( I 2 = 0%; Figure 3A ).
Women had significantly better 11-item Alzheimer’s Disease Assessment Scale–Cognitive subscale (ADAS-Cog, 70-point scale) scores than men ( P = 0.001) and showed a trend toward younger age ( P = 0.11).
MODS from day 3 to day 7 showed a trend toward improvement in the centhaquine group (MODS 1.37 to 0.82, p = 0.11) and toward deterioration in the control group (MODS 1.14 to 1.73) [ 30 ].
Patient cortical thickness did not differ from that of HCs in the RIFG ( p > 0.91, d = 0.036), while the LIFG showed a trend and a much larger effect size ( p < 0.11, d = 0.591).
Out of 5 targets tested ( Klf4, Enos , Ctnnb1 , Bcl2l1 and Sma) , only the expression of Klf4 was significantly upregulated (p = 0.05), while the changes in Sma showed a trend (p = 0.11) without reaching a statistical significance (see Supplementary Fig.
7.7%; p = 0.039) than those without radicular symptoms, and showed a trend towards being more likely to have had a prior history of sciatica (12.9% vs. 3.8%; p = 0.11), but were otherwise comparable with respect to covariates examined (data not shown).
Among the locations, only subserous leiomyomas showed a trend towards a reduced probability of DO ( p = 0.11, versus submucous and p = 0.12, versus intramural).
Because BMI itself showed a trend (p = 0.11) for an association with fibrosis even in the high-RILA subgroup (Supplementary Fig.
We also analyzed the time of SARS-CoV-2 clearance as a function of CD4 count and HIV status and found that while participants with a low CD4 count (<200) showed a trend of longer time to SARS-CoV-2 clearance (p=0.11), HIV viremia had no effect ( Figure 1—figure supplement 5 ).